Samir Shah, MD and CEO of NCDEX says MCX trading volume has reduced post the NSEL crisis. Currently, MCX has a market share of 80 percent and NCDEX 15 percent.
The MCX deal was done at a valuation of about Rs 3000 crore, about 20 times of its FY14 earnings. Samir Shah, MD and CEO of NCDEX says valuation reflects the current market scenario and everything that has been happened over the past one year.
He says the MCX trading volume has reduced post the NSEL crisis. Currently, MCX has a market share of 80 percent and NCDEX 15 percent. But, the important thing according to Shah is that the open interest market share has moved towards NCDEX from MCX.
Stay tuned for more…
Anda sedang membaca artikel tentang
MCX deal volume reflects current mkt scenario: NCDEX
Dengan url
https://kesehatanda.blogspot.com/2014/07/mcx-deal-volume-reflects-current-mkt.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
MCX deal volume reflects current mkt scenario: NCDEX
namun jangan lupa untuk meletakkan link
MCX deal volume reflects current mkt scenario: NCDEX
sebagai sumbernya
0 komentar:
Posting Komentar